Martingale Asset Management L P United Therapeutics Corp Transaction History

Martingale Asset Management L P

  • $4.01 Billion
  • Q4 2024

A detailed history of Martingale Asset Management L P transactions in United Therapeutics Corp stock. As of the latest transaction made, Martingale Asset Management L P holds 34,652 shares of UTHR stock, worth $12.4 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
34,652
Previous 37,102 6.6%
Holding current value
$12.4 Million
Previous $13.3 Million 8.04%
% of portfolio
0.31%
Previous 0.31%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$348.66 - $410.0 $854,217 - $1 Million
-2,450 Reduced 6.6%
34,652 $12.2 Million
Q3 2024

Nov 14, 2024
SELL
$311.04 - $363.55 $1.76 Million - $2.06 Million
-5,664 Reduced 13.24%
37,102 $13.3 Million
Q2 2024

Aug 12, 2024
SELL
$228.26 - $319.04 $1.26 Million - $1.77 Million
-5,537 Reduced 11.46%
42,766 $13.6 Million
Q1 2024

May 14, 2024
SELL
$210.76 - $249.51 $1.59 Million - $1.88 Million
-7,525 Reduced 13.48%
48,303 $11.1 Million
Q4 2023

Feb 12, 2024
SELL
$214.88 - $256.94 $53,720 - $64,235
-250 Reduced 0.45%
55,828 $12.3 Million
Q3 2023

Nov 14, 2023
SELL
$211.82 - $248.24 $845,161 - $990,477
-3,990 Reduced 6.64%
56,078 $12.7 Million
Q2 2023

Aug 11, 2023
SELL
$205.19 - $232.99 $602,437 - $684,058
-2,936 Reduced 4.66%
60,068 $13.3 Million
Q1 2023

May 12, 2023
BUY
$212.99 - $276.17 $375,075 - $486,335
1,761 Added 2.88%
63,004 $14.1 Million
Q4 2022

Feb 13, 2023
SELL
$205.95 - $280.43 $416,430 - $567,029
-2,022 Reduced 3.2%
61,243 $17 Million
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $1.65 Million - $1.99 Million
8,140 Added 14.77%
63,265 $13.2 Million
Q2 2022

Aug 11, 2022
BUY
$174.81 - $241.14 $1.1 Million - $1.52 Million
6,307 Added 12.92%
55,125 $13 Million
Q1 2022

May 12, 2022
BUY
$166.16 - $213.96 $2.07 Million - $2.66 Million
12,434 Added 34.17%
48,818 $8.76 Million
Q4 2021

Feb 11, 2022
BUY
$184.32 - $216.08 $5.33 Million - $6.25 Million
28,944 Added 389.03%
36,384 $7.86 Million
Q3 2021

Nov 12, 2021
SELL
$179.86 - $214.88 $14.7 Million - $17.6 Million
-81,937 Reduced 91.68%
7,440 $1.37 Million
Q2 2021

Aug 13, 2021
SELL
$170.47 - $211.93 $1.14 Million - $1.42 Million
-6,694 Reduced 6.97%
89,377 $16 Million
Q1 2021

May 13, 2021
BUY
$153.94 - $174.85 $4.64 Million - $5.27 Million
30,160 Added 45.76%
96,071 $16.1 Million
Q4 2020

Feb 10, 2021
BUY
$101.87 - $151.79 $2.4 Million - $3.58 Million
23,602 Added 55.78%
65,911 $10 Million
Q3 2020

Nov 12, 2020
BUY
$99.9 - $121.13 $2.79 Million - $3.39 Million
27,976 Added 195.19%
42,309 $4.27 Million
Q2 2020

Aug 10, 2020
BUY
$92.74 - $125.82 $1.33 Million - $1.8 Million
14,333 New
14,333 $1.73 Million

Others Institutions Holding UTHR

# of Institutions
723
Shares Held
60.9M
Call Options Held
123K
Put Options Held
104K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email